Cargando…
Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma
In this study, 5-fluorouracil (5-FU) and LY294002 (LY)-loaded PEGylated nanoliposome was prepared to target esophageal squamous cell carcinoma (ESCC). The particles were characterized in terms of physicochemical and biological parameters. The co-delivery of autophagy inhibitor and chemotherapeutic d...
Autores principales: | Feng, Ye, Gao, Yongjian, Wang, Dayu, Xu, Zhonghang, Sun, Weixuan, Ren, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192941/ https://www.ncbi.nlm.nih.gov/pubmed/30328537 http://dx.doi.org/10.1186/s11671-018-2716-x |
Ejemplares similares
-
Development and characterization of lactoferrin nanoliposome: cellular uptake and stability
por: Guan, Rongfa, et al.
Publicado: (2012) -
LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells
por: Shin, Jung-Young, et al.
Publicado: (2010) -
Mesoporous Silica Nanoparticle–Based Combination of NQO1 Inhibitor and 5-Fluorouracil for Potent Antitumor Effect Against Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Chen, Jing, et al.
Publicado: (2019) -
Investigation on Physicochemical Characteristics of a Nanoliposome-Based System for Dual Drug Delivery
por: Nam, Jae Hyun, et al.
Publicado: (2018) -
Comparative Analysis of the Antineoplastic Activity of C(60) Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo
por: Lynchak, O. V., et al.
Publicado: (2017)